
Primary Clinic (Direct GLP) Review
Semaglutide & tirzepatide GLP-1 weight-loss telehealth · Independently scored 6.6/10
Best for: GLP-1 at wholesale cost inside a Direct Primary Care membership
Price is where Primary Clinic (Direct GLP) scores best in our breakdown.
Semaglutide
Tirzepatide
Price checked on Primary Clinic (Direct GLP)’s site,
What the monthly price covers
Medication
Not stated
Provider visits
Not stated
Shipping
Not stated
Lab work
Not stated
Coaching
Not stated
No insurance needed · Vetted by our editors
Primary Clinic (Direct GLP) is a Direct Primary Care membership rather than the usual direct-to-consumer GLP-1 marketplace. For $89/mo members get unlimited primary care, direct text access, same-day virtual visits and routine labs, then buy compounded 503A GLP-1s at wholesale cost with nothing added: semaglutide from $85/mo, tirzepatide from $133/mo. Currently available in 10 states, with medication monitoring built into an ongoing care relationship.
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. How we make money
Vetted alternatives to Primary Clinic (Direct GLP)
Ro
Best for: FDA-approved brand GLP-1s, including the Wegovy pill and Foundayo, with insurance help
Editorial score · methodology
Collective
Best for: the lowest flat medication price if you can absorb an annual membership fee
Editorial score · methodology
CoreAge Rx
Best for: lowest-price compounded semaglutide and tirzepatide with one flat price at every dose
Editorial score · methodology

from $85/mo (+ required membership) · no insurance needed
Primary Clinic (Direct GLP) at a glance
- Type
- GLP-1 telehealth provider
- Medications
- Semaglutide, Tirzepatide
- Starting price
- $85/mo (+ required membership)
- Pricing model
- Scales with dose: higher doses cost more
- Availability
- 17 states + DC
- FDA status
- No FDA warning letter on record
How we scored Primary Clinic (Direct GLP)
Each dimension is scored algorithmically from Primary Clinic (Direct GLP)’s published pricing, drugs offered, verification status, and disclosed inclusions, using the same six-dimension framework we apply to every provider.
Value25%
7.8/10Primary Clinic (Direct GLP)'s $85/mo covers the medication only; a required membership or program fee is billed on top, so the all-in monthly cost is more than that figure. For comparison, the median for GLP-1 providers (each program's lowest listed ongoing monthly price for compounded semaglutide) is $179. Note the price scales with dose, so budget for higher tiers as you titrate.
Effectiveness25%
7.0/10Primary Clinic (Direct GLP) offers both semaglutide and tirzepatide, the two GLP-1 molecules with the strongest published weight-loss trial outcomes.
User Experience15%
5.8/10Online intake and platform experience; 4 platform features disclosed.
Trust & Safety15%
6.7/10Key details fully confirmed by our editors; no FDA warning letters on file.
Accessibility10%
5.4/10Primary Clinic (Direct GLP) is available in 17 states plus DC. Confirm yours is covered.
Support10%
4.8/10Primary Clinic (Direct GLP) provides standard clinician follow-up; no extended coaching or community program is disclosed.
Each checked against the provider’s own site.
Providers that don’t post pricing up front score lower on Value and carry a cost-transparency note in their review. Read the full methodology →
How we verified this Primary Clinic (Direct GLP) review
Last checked November 2026- Confirmed current pricing across 8 dose/plan tiers
- Confirmed availability in 17 states plus DC
- Checked the FDA warning-letter database for enforcement actions
- Walked the provider's public sign-up flow, stopping before payment
Pricing, availability, and compliance facts come from the provider's own site and primary regulatory records. See the sources below. Editorial confidence in this data: high.
What we checked
- Provider's own pricing page
- $85–$258/mo across 8 dose/plan tiers (checked November 2026)
- FDA warning-letter register
- No letter on file for this provider
What to expect when you sign up with Primary Clinic (Direct GLP)
We walked Primary Clinic (Direct GLP)’s public signup flow in July 2026 to document the process (the steps, pricing transparency, and what’s required) before you commit. (We don’t create accounts, enter medical information, or check out; this is the observable funnel, not a prescribing outcome.)
- 1Take a short eligibility quiz covering your health and medical history.
- 2A licensed provider evaluates your information and determines a treatment plan and prescription if appropriate.
- 3If prescribed, a US-based state-licensed pharmacy ships the medication to you for free.
- The Direct GLP website now redirects to ReflexMD; the live brand is ReflexMD.
- Plans are shown up front on the homepage: compounded Semaglutide $199/mo, compounded Tirzepatide $297/mo, and oral weight-control tablets $199/mo.
- Marketed as flat-rate pricing with free and discreet shipping and FSA/HSA eligibility; a promo (code MIDYEAR15) advertises 15% off 3-month plans.
- The consultation is completed by answering online medical questions (asynchronous); patients can message a doctor 24/7. No lab test or video visit is stated as required.
- Site claims over 75,000 patients served.
Primary Clinic (Direct GLP) customer support
- Phone
- +1 888-807-2462
- help@reflexmd.com
GLP-1 medications Primary Clinic (Direct GLP) offers
Tap any medication to read our plain-English guide: how it works, dosing, side effects, and what the trials found.
Pricing
Prices re-verified
Ready to get started?
Plans and promotions change often, so check Primary Clinic (Direct GLP)'s current pricing and active discounts before you decide.
What we like
- Direct Primary Care model integrates GLP-1 with continuous primary care, unlike most direct-to-consumer platforms
- GLP-1 at wholesale cost with nothing added: semaglutide from $85/mo, tirzepatide from $133/mo (members only)
- Unlimited primary care visits, direct text access, and same-day care bundled in the $89/mo membership
- Routine labs and thousands of medications included in membership, so no surprise bills
- Per-dose pricing shown publicly for all 8 dose tiers of both semaglutide and tirzepatide
- Publishes the FDA 503A compounded-medication disclaimer
Watch-outs
- 18 states only (AZ, CO, DC, FL, GA, IA, ID, KS, MT, NE, NM, NV, NY, OK, OR, UT, VA, WA), which is limited vs 50-state platforms
- Membership required to access wholesale pricing: $89/mo adds ~$1,068/yr in fixed cost
- 503A pharmacy partners not named
- LegitScript certification not mentioned on the site
- Medical director and corporate legal entity not disclosed
- Compounded only, with no brand-name Wegovy, Ozempic, Mounjaro, or Zepbound
- Refund policy not disclosed publicly
A primary-care practice that also sells GLP-1s
Primary Clinic (its web address is where the "Direct GLP" alt-name comes from) is built differently from almost every other name we review. Most platforms here are direct-to-consumer storefronts: you pay a bundled monthly fee, a medication shows up, and the clinical relationship is thin. Primary Clinic is a Direct Primary Care (DPC) membership first. You join for a flat monthly fee that buys unlimited primary care, then you buy compounded semaglutide or tirzepatide separately at the clinic's wholesale cost, with nothing added on top. If you want an ongoing care relationship wrapped around your GLP-1 and you live in one of its ten states, it's one of the more interesting setups we've reviewed. If you just want the cheapest no-strings vial mailed to your door, the math works against you.
How the two-part price works
You pay two separate bills here. The first is the membership: a flat fee in the high eighties per month that covers unlimited primary care, direct text access to a provider, same-day virtual visits, routine labs, and what the clinic describes as thousands of medications, with no co-pays or deductibles. The second is the medication itself, billed separately at wholesale. Compounded semaglutide starts at $85 a month (+ required membership) for the lowest doses and rises with the dose; tirzepatide starts in the low three figures and climbs as you titrate up. Both drugs publish every dose tier openly (eight tiers in total), so you can see exactly what month four or month six will cost before you ever sign up.
Judge it on the all-in number. Add the membership to a low-dose vial and you're paying noticeably more than the category median of $179 for the drug alone. That total also buys primary care, labs, and provider access. Against a typical telehealth bundle, and certainly against paying over a thousand dollars a month for brand-name GLP-1s elsewhere, the package can come out ahead for the right person. For someone who only wants a vial and nothing else, the membership is pure overhead: roughly a thousand dollars a year of fixed cost you don't need.
How we get the market median: $179 is the middle value of each program's lowest listed ongoing monthly price for compounded semaglutide (month to month, not a first-month promo, a prepaid plan or a price with a membership on top), across the 121 programs that publish one.
Wholesale pricing with nothing added on top
Primary Clinic doesn't treat the GLP-1 as a profit center. The medication is passed through at the clinic's wholesale cost, explicitly "with no hidden markups," because the clinic makes its money on the membership. In the standard playbook, the drug carries the margin. Here your per-dose price is unusually transparent and unusually low for the drug itself, and the clinic has no incentive to push you toward a pricier dose or formulation. For patients who've felt nickel-and-dimed by other platforms (surprise consult fees, dose-based upcharges, opaque bundles), this is a refreshing structure.
The medications and how they're dispensed
Primary Clinic offers compounded semaglutide and compounded tirzepatide, both made by licensed 503A pharmacies. There is no brand-name option here (no Wegovy, Ozempic, Mounjaro, or Zepbound) and no oral formulation, so this is injectable compounded medication only. To its credit, the clinic publishes the standard FDA 503A disclaimers plainly: these compounded products are not FDA-approved brand-name medications and are "not affiliated with or approved as generic versions of brand-name GLP-1 medications," even though they contain the same active ingredients. That kind of upfront labeling is what we want to see from any compounding-based provider, and it's a point in the clinic's favor on the trust side.
Where the transparency stops
For a provider that's this open about price, a few important things stay hidden. The specific 503A pharmacy partners are never named; you're told the medication comes from licensed compounders, but not which ones, which makes it harder to vet sourcing independently. There's no LegitScript certification mentioned on the site, no named medical director, and no disclosed corporate legal entity. The refund policy isn't published either. None of these are red flags on their own. The per-dose pricing, the ten-state list, and the 503A language are all printed on the site for anyone to read. But they are gaps, and they hold the clinic back on oversight transparency.
Availability: ten states only
This is a meaningful limit. Primary Clinic currently serves only Washington, New Mexico, Arizona, Utah, Florida, DC, Kansas, Oklahoma, Virginia, and Georgia, with more promised. The DPC model, built on continuous hands-on primary care, is harder to scale across all fifty states than a pure mail-order operation, so the narrow footprint is partly a consequence of the model itself. If you're outside those ten states, this provider simply isn't an option yet, and a 50-state platform will serve you instead. Floridians who want in-person care can also look at Garcia Weight Loss, a Tampa Bay clinic open since 2000 that runs provider-supervised GLP-1 programs with lab monitoring.
Who should choose it, and who should skip it
- Choose it if: you live in one of the ten states, you want your GLP-1 managed inside an ongoing primary-care relationship with labs and direct provider access, and you value transparent wholesale drug pricing over the absolute lowest sticker number.
- Choose it if: you're already paying for fragmented care elsewhere and would happily consolidate primary care, labs, and weight management under one flat membership.
- Skip it if: you only want a compounded vial with no membership commitment, since the flat monthly fee makes the all-in cost higher than drug-only competitors.
- Skip it if: you need brand-name Wegovy, Ozempic, Mounjaro, or Zepbound, an oral option, or you want a named pharmacy and published medical director before you'll trust a provider.
- Skip it if: you live outside its ten-state service area.
The bottom line
Primary Clinic is one of the few providers we've reviewed where primary care is the main course and the GLP-1 is the side dish. The Direct Primary Care membership plus wholesale-priced medication is a patient-friendly structure, and the published per-dose pricing and clear 503A disclaimers earn it trust. Holding it back are the ten-state footprint, the unavoidable membership overhead if you only want the drug, and the undisclosed pharmacy partner, medical director, and corporate entity. For the patient who wants continuous care wrapped around their weight-loss medication and lives in the right state, it's a strong choice. For the bargain-hunter who just wants the cheapest vial, look elsewhere and compare the all-in cost using our scoring methodology.
The Bottom Line
Price is where Primary Clinic (Direct GLP) scores best in our breakdown.
Ready to start with Primary Clinic (Direct GLP)?
From $85/mo (+ required membership). See current pricing and start your free consultation.
Primary Clinic (Direct GLP) might not be your best fit if…
We rank editorially, so here’s where a different provider we track may serve you better.
- If you want brand-name Ozempic, Wegovy, Mounjaro or Zepbound, consider altRX.
- If you want built-in coaching and behavior-change support, consider Ro.
- If you live outside its coverage area and need nationwide access, consider CoreAge Rx.
Head-to-head
Compare Primary Clinic (Direct GLP) vs…
Primary Clinic (Direct GLP) scores6.6/10
Side-by-side pricing, medications and scores. Pick a matchup.
Primary Clinic (Direct GLP) vs Amazon One Medical
Amazon One Medical scores 8.5/10

Primary Clinic (Direct GLP) vs Vytora Health
Vytora Health scores 8.4/10
Scores are our independent editorial ratings out of 10.
Frequently Asked Questions
Key terms, explained
New to GLP-1s? Tap any term for a quick, plain-English definition.
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
- Compounded GLP-1 · Pharmacy and drug forms
- 503A pharmacy · Pharmacy and drug forms
- PCAB accreditation · Pharmacy and drug forms
- Prior authorization (PA) · Insurance and regulatory
- Off-label use · Insurance and regulatory
- FDA Drug Shortage List · Insurance and regulatory
Sources
The primary regulatory filings and peer-reviewed studies cited throughout this Primary Clinic (Direct GLP) review:
Sources & methodology (as of November 2026)
- 1.Weight Loss Rankings — GLP-1 Pricing Index 2026 (our independent dataset)— WeightLossRankings.org.
- 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
- 3.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
- 4.PCAB — Pharmacy Compounding Accreditation Board Standards— Accreditation Commission for Health Care (ACHC) / PCAB.
- 5.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
- 6.STEP 1 Trial — Once-Weekly Semaglutide in Adults with Overweight or Obesity (Wilding JPH et al.)— New England Journal of Medicine.PMID: 33567185.
- 7.FDA — Wegovy (semaglutide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 8.FDA — Ozempic (semaglutide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 9.SURMOUNT-1 Trial — Tirzepatide Once Weekly for the Treatment of Obesity (Jastreboff AM et al.)— New England Journal of Medicine.PMID: 35658024.
- 10.FDA — Zepbound (tirzepatide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 11.FDA — Mounjaro (tirzepatide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 12.SURMOUNT-5 Trial — Tirzepatide vs. Semaglutide Head-to-Head in Obesity (Garvey WT et al.)— New England Journal of Medicine.PMID: 40334173.
See Primary Clinic (Direct GLP)'s current pricing
Plans from $85/mo (+ required membership). Start your free consultation to check eligibility and today's price.